Regentis Biomaterials RGNT Estimates

NYSE RGNT
$2.06 -0.17 (-7.46%)
As of: Aug 20, 2026 · 3:59 PM EDT

Detailed analyst consensus, revenue, and earnings forecasts vs reported data.

Annual Revenue Estimates

Metric 20252026
Reported (Actual) 0.00-
High Estimate -0.00
Low Estimate -0.00
Consensus Estimate -0.00

Annual Earnings Per Share (EPS) Estimates

Metric 20252026
Reported (Actual) -24.16-
High Estimate --0.60
Low Estimate --0.66
Consensus Estimate --0.63